Ahmad Sulaiman

Summary

Affiliation: University of Malaya
Country: Malaysia

Publications

  1. ncbi request reprint Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia
    Mas Ayu Said
    Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
    Singapore Med J 53:801-7. 2012
  2. pmc A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
    Danielle Coppola
    Janssen Research and Development, LLC, Raritan, New Jersey, USA
    BMC Psychiatry 12:26. 2012
  3. ncbi request reprint Safety and efficacy of rapid dose administration of quetiapine in bipolar mania
    A Hatim
    Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
    Hum Psychopharmacol 21:313-8. 2006

Collaborators

  • Mas Ayu Said
  • Danielle Coppola
  • A Hatim
  • Abdul Kadir Abu Bakar
  • Mahesh N Samtani
  • Rosliwati Md Yusoff
  • Isaac Nuamah
  • David W Hough
  • Shamshunnisah Abu Bakar
  • Srihari Gopal
  • Gahan Pandina
  • Yanning Liu
  • Tsui Huei Loo
  • Mohd Hussain Habil
  • Srijit Das
  • Bart Remmerie
  • S T Jambunathan
  • N Z Zuraida
  • C C Low
  • S G Jesjeet
  • H Habil
  • J Joseph

Detail Information

Publications3

  1. ncbi request reprint Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia
    Mas Ayu Said
    Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
    Singapore Med J 53:801-7. 2012
    ..This study aimed to determine the prevalence of metabolic syndrome and risk of coronary heart disease (CHD) in patients with schizophrenia receiving antipsychotics in Malaysia...
  2. pmc A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
    Danielle Coppola
    Janssen Research and Development, LLC, Raritan, New Jersey, USA
    BMC Psychiatry 12:26. 2012
    ..This study evaluates safety and tolerability, as well as pharmacokinetics, of the highest marketed dose of PP (150 mg eq. [234 mg]) in stable patients with schizophrenia over a 1-year period...
  3. ncbi request reprint Safety and efficacy of rapid dose administration of quetiapine in bipolar mania
    A Hatim
    Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
    Hum Psychopharmacol 21:313-8. 2006
    ..Most patients tolerated rapid titration of quetiapine to 800 mg/day by day 4 of therapy, with a significant improvement in manic symptoms by day 7 of treatment...